J&J Acquires Listerine, Lubriderm As Part Of $16.6 Bil. Pfizer Deal
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson's successful bid to acquire Pfizer Consumer Healthcare augments the company's oral care division into a billion dollar-plus business and expands the segment's global reach, the company said
You may also be interested in...
C&D, Chattem Stay Alert For Premium Properties Unloaded From Bigger Firms
Lean and hungry Church & Dwight and Chattem remain ready to pounce on choice morsels that bigger firms may drop from the table, but recognize that too much growth could jeopardize one of their chief competitive advantages
C&D, Chattem Stay Alert For Premium Properties Unloaded From Bigger Firms
Lean and hungry Church & Dwight and Chattem remain ready to pounce on choice morsels that bigger firms may drop from the table, but recognize that too much growth could jeopardize one of their chief competitive advantages
J&J Has Faith In Listerine Despite Projected Oral-Care Slowdown
Johnson and Johnson is optimistic that its oral-care business will continue to grow, led by mouthwash and floss, despite forecasts for a slowdown in the category worldwide